Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy

ABSTRACT Objective: Fixed combinations of 0.2% brimonidine-0.5% timolol and 2% dorzolamide-0.5% timolol are used to lower intraocular pressure (IOP). The objective of this study was to evaluate the IOP-lowering efficacy and ocular tolerability of brimonidine-timolol compared with dorzolamide-timolol...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current medical research and opinion 2009-07, Vol.25 (7), p.1645-1653
Hauptverfasser:	Nixon, Donald R., Yan, David B., Chartrand, Jean-Pierre, Piemontesi, Roberto L., Simonyi, Susan, Hollander, David A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antihypertensive Agents - administration & dosage Antihypertensive Agents - adverse effects Brimonidine Brimonidine Tartrate Dorzolamide Drug Combinations Female Fixed combination Glaucoma Humans Intraocular pressure Intraocular Pressure - drug effects Male Middle Aged Ocular Hypertension - drug therapy Ophthalmic Solutions - administration & dosage Osmolar Concentration Quinoxalines - administration & dosage Quinoxalines - adverse effects Sulfonamides - administration & dosage Sulfonamides - adverse effects Thiophenes - administration & dosage Thiophenes - adverse effects Time Factors Timolol Timolol - administration & dosage Timolol - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!